» Articles » PMID: 28188427

The Prognostic Value of Right Ventricular Long Axis Strain in Non-ischaemic Dilated Cardiomyopathies Using Standard Cardiac Magnetic Resonance Imaging

Overview
Journal Eur Radiol
Specialty Radiology
Date 2017 Feb 12
PMID 28188427
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate the association of right ventricular long axis strain (RV-LAS), a parameter of longitudinal function, with outcome in patients with non-ischaemic dilated cardiomyopathy (NIDCM).

Methods: In 441 patients with NIDCM, RV-LAS was analysed retrospectively by measuring the length between the epicardial border of the left ventricular apex and the middle of a line connecting the origins of the tricuspidal valve leaflets in end-diastole and end-systole on non-contrast standard cine sequences.

Results: The primary endpoint (cardiac death or heart transplantation) occurred in 41 patients, whereas 95 reached the combined endpoint (including cardiac decompensation and sustained ventricular arrhythmias) during a median follow-up of 4.2 years. Kaplan-Meier survival curves showed a poor outcome in patients with RV-LAS values below -10% (log-rank, p < 0.0001). In a risk stratification model RV-LAS improved prediction of outcome in addition to RV ejection fraction (RVEF) and presence of late gadolinium enhancement. Assessment of RV-LAS offered incremental information compared to clinical symptoms, biomarkers and RVEF. Even in the subgroup with normal RVEF (>45%, n = 213) reduced RV-LAS was still associated with poor outcome.

Conclusion: Assessment of RV-LAS is an independent indicator of outcome in patients with NIDCM and offers incremental information beyond clinical and cardiac MR parameters.

Key Points: • Impaired right ventricular longitudinal function (RV-LAS) is associated with poorer cardiac outcomes. • Poor outcome is associated with decreased RV-LAS even in patients with RVEF >45%. • Addition of RV-LAS to known risk factors enhances the power prognostic information.

Citing Articles

Cardiac Magnetic Resonance Imaging in the Evaluation of Functional Impairments in the Right Heart.

Negru A, Tarcau B, Agoston-Coldea L Diagnostics (Basel). 2024; 14(22).

PMID: 39594247 PMC: 11593124. DOI: 10.3390/diagnostics14222581.


Risk Stratification in Nonischemic Dilated Cardiomyopathy Using CMR Imaging: A Systematic Review and Meta-Analysis.

Eichhorn C, Koeckerling D, Reddy R, Ardissino M, Rogowski M, Coles B JAMA. 2024; .

PMID: 39298146 PMC: 11413760. DOI: 10.1001/jama.2024.13946.


Prognostic Value of Cardiac Magnetic Resonance in Assessing Right Ventricular Strain in Cardiovascular Disease: A Systematic Review and Meta-Analysis.

Bo K, Zhou Z, Sun Z, Gao Y, Zhang H, Wang H Rev Cardiovasc Med. 2024; 23(12):406.

PMID: 39076664 PMC: 11270452. DOI: 10.31083/j.rcm2312406.


Impact of late gadolinium-enhanced cardiac MRI on arrhythmic and mortality outcomes in nonischemic dilated cardiomyopathy: updated systematic review and meta-analysis.

Theerasuwipakorn N, Chokesuwattanaskul R, Phannajit J, Marsukjai A, Thapanasuta M, Klem I Sci Rep. 2023; 13(1):13775.

PMID: 37612359 PMC: 10447440. DOI: 10.1038/s41598-023-41087-4.


Right Ventricular Longitudinal Strain in Patients with Heart Failure.

Ji M, Wu W, He L, Gao L, Zhang Y, Lin Y Diagnostics (Basel). 2022; 12(2).

PMID: 35204536 PMC: 8871506. DOI: 10.3390/diagnostics12020445.


References
1.
Maron B, Towbin J, Thiene G, Antzelevitch C, Corrado D, Arnett D . Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and.... Circulation. 2006; 113(14):1807-16. DOI: 10.1161/CIRCULATIONAHA.106.174287. View

2.
Gulati A, Ismail T, Jabbour A, Alpendurada F, Guha K, Ismail N . The prevalence and prognostic significance of right ventricular systolic dysfunction in nonischemic dilated cardiomyopathy. Circulation. 2013; 128(15):1623-33. DOI: 10.1161/CIRCULATIONAHA.113.002518. View

3.
Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P . Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2007; 29(2):270-6. DOI: 10.1093/eurheartj/ehm342. View

4.
Gulati A, Jabbour A, Ismail T, Guha K, Khwaja J, Raza S . Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA. 2013; 309(9):896-908. DOI: 10.1001/jama.2013.1363. View

5.
Michels V, Driscoll D, Miller F, Olson T, Atkinson E, Olswold C . Progression of familial and non-familial dilated cardiomyopathy: long term follow up. Heart. 2003; 89(7):757-61. PMC: 1767723. DOI: 10.1136/heart.89.7.757. View